Guideline for the management of clinically localized prostate cancer: 2007 update
Guideline for the management of clinically localized prostate cancer: 2007 update
复制标题
DOI：
10.1016/j.juro.2007.03.003
复制
发表时间：
2007-06-01
影响因子：
6.6
通讯作者：
Tangen, Catherine M.
中科院分区：
文献类型：
--
作者：
Thompson, Ian;Thrasher, James Brantley;Tangen, Catherine M.
1995年12月，AUA发表了《临床局限性前列腺癌的治疗报告》。1该文件是17名临床医生和科学家六年工作的成果，需要对12,501份科学出版物进行评估，并从165篇符合专家小组严格标准的论文中详细摘录信息(在线附录1)。小组注意到，由于缺乏证据，无法就个别病人的最佳治疗提出具体建议，应向哪些病人提供所有治疗选择，病人的偏好应指导决策。自1995年以来，美国约有260万名男性2被诊断出患有前列腺癌，近375,000名男性3、4死于这种疾病。此外，国家癌症研究所第四研究所在前列腺癌研究上花费了21亿美元，截至2005年11月，约有28,111篇关于前列腺癌的科学论文发表在同行评议的医学期刊上(Ovid Search，1995年12月31日至2005年10月23日；Key
In December 1995, the AUA published the Report on the Management of Clinically Localized Prostate Cancer. 1The document was the culmination of six years of work by 17 clinicians and scientists and required the evaluation of 12,501 scientific publications with the detailed extraction of information from 165 papers that met the rigorous criteria of the panel of experts (Appendix 1 on-line). The Panel noted that a lack of evidence precluded specific recommendations for optimal treatment of an individual patient, which patients should be offered all treatment options, and that patient preferences should guide decision making. Since 1995, approximately 2,600,000 men 2 in the United States have been diagnosed with prostate cancer, and nearly 375,000 men 3, 4 have lost their lives to this disease. In addition, the National Cancer Institute 4 has spent $2.1 billion on prostate cancer research and as of November 2005, approximately 28,111 scientific papers concerning prostate cancer have been published in peer-reviewed medical journals (OVID Search, December 31, 1995 to October 23, 2005; key